Interestingly, however, survival was similar for patients with sarcomas with and without ATRX alterations when all patients were treated with radiation therapy (Figure 1F), suggesting that a ATRX loss-of-function mutation may increase the radiation response of soft tissue sarcomas. The gene discussed is ATRX; the disease is soft tissue sarcoma.